LeafNLP Demos
Back to explore

Report #2875307

Received Nov 27, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
28 yrs
State
TX
Recovered
Unknown
Vaccinated
Nov 21, 2025
Onset
Nov 21, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2——

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

a patient got a First dose of the SHINGRIX vaccine at their facility on November ninth and received a Second dose on November twenty first on a different location; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 28-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 09-NOV-2025, expiry date 16-Sep-2026). On 21-NOV-2025, the patient received the 2nd dose of Shingrix. On 21-NOV-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: a patient got a First dose of the SHINGRIX vaccine at their facility on November ninth and received a Second dose on November twenty first on a different location). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK Receipt Date: 24-NOV-2025 Patient got a first dose of the Shingrix vaccine at their facility on November ninth Patient received a Second dose on November twenty first on a different location. The batch number was not provided and a request for this information has been made.